Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs

被引:27
|
作者
Beall, HD [1 ]
Sloan, KB [1 ]
机构
[1] UNIV FLORIDA,DEPT MED CHEM,GAINESVILLE,FL 32610
关键词
1-alkylcarbonyl-5-FU; diffusion cell; water and lipid solubility; partition coefficients; flux; skin accumulation; solubility parameters;
D O I
10.1016/0378-5173(95)04327-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The members of a series of 1-alkylcarbonyl-5-FU prodrug derivatives have been characterized and evaluated for their abilities to deliver 5-FU into and through skin. There was no correlation of lipid solubility or partition coefficient with relative abilities of the members of the 1-alkylcarbonyl series to deliver 5-FU through skin. However, there was a correlation with water solubility within the series. Although their lipid solubilities and partition coefficient values were greater than those of the 1-alkyloxycarbonyl series, only 1-acetyl-5-FU was more soluble in water, and only 1-acetyl-5-FU delivered more total 5-FU species through the skin than the corresponding member of the 1-alkyloxycarbonyl series. On the other hand, the 1-alkylcarbonyl series was more effective at enhancing the ratio of dermal to transdermal delivery (D/T delivery ratio) than the 1-alkyloxycarbonyl series, presumably because of the rapid hydrolysis of the members of the former series once contact with the aqueous domains of the epidermis had been made. Thus, the hypothesis that enhanced D/T delivery ratio requires rapid hydrolysis of the prodrug after it partitions into the skin is supported. Although the prodrugs hydrolyzed rapidly in water, they were stable in isopropyl myristate (IPM) during their application in IPM to highly hydrated skin. There was also a good correlation of calculated solubility parameters for the prodrugs with their permeability coefficients.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [31] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [32] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [33] Intraoperative 5-fluorouracil (5-FU) with postoperative 5-FU injections versus postoperative injections only in primary trabeculectomies
    Urken, SI
    Skuta, GL
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 117 - 117
  • [34] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
  • [35] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
  • [36] Layered inorganic nanocomposites: A promising carrier for 5-fluorouracil (5-FU)
    Kevadiya, Bhavesh D.
    Patel, Tapan A.
    Jhala, Devendrasinh D.
    Thumbar, Rahul P.
    Brahmbhatt, Harshad
    Pandya, Maharshi P.
    Rajkumar, Shalini
    Jena, Prasant K.
    Joshi, Ghanshyam V.
    Gadhia, Pankaj K.
    Tripathi, C. B.
    Bajaj, Hari C.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (01) : 91 - 101
  • [37] DETERMINATION OF 5-FLUOROURACIL (5-FU) IN SERUM OF CANCER TREATED PATIENTS
    COSYNSDUYCK, MC
    DELEENHEER, AP
    VANVAERENBERGH, PM
    [J]. CLINICAL CHEMISTRY, 1975, 21 (07) : 1024 - 1024
  • [38] CONTINUOUS 5-FLUOROURACIL (5-FU) INFUSION IN REFRACTORY CARCINOMA OF THE BREAST
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    BEATTY, P
    ANDERSON, T
    JENKINS, D
    FRICK, J
    AUSMAN, R
    [J]. CLINICAL RESEARCH, 1986, 34 (04): : A931 - A931
  • [39] Effect of 5-fluorouracil (5-FU) infusion in myocardial perfusion scans
    Bishiniotis, T
    Mouratidou, D
    Pentheroudakis, G
    Andreadis, C
    Katseas, G
    Litos, A
    Hatseras, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 60 - 60
  • [40] Inhibition of lens epithelial growth using 5-fluorouracil (5-FU)
    McCauley, MB
    Scribbick, FW
    Reitstetter, RE
    Chapa, I
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46